anmelden
SMI Expanded
1.972,28
PKT
-10,97
PKT
-0,55
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SMI Expanded-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 24.05.05 | Swiss Life kaufen | Nord LB | |
| 26.05.05 | Swiss Life kaufen | Nord LB | |
| 20.05.05 | Zurich Insurance | DZ-Bank | |
| 20.05.05 | Swiss Life buy | Smith Barney Citigroup | |
| 20.05.05 | Swiss Life buy | Smith Barney Citigroup | |
| 24.05.05 | Roche buy | Jyske Bank | |
| 26.05.05 | Roche buy | Jyske Bank | |
| 21.09.05 | Swiss Life | Nord LB | |
| 20.05.05 | Swiss Life | Nord LB | |
| 26.05.05 | Swiss Life | Nord LB | |
| 19.05.05 | Zurich Insurance Halten | Helaba Trust | |
| 19.05.05 | Swiss Life Neutral | HypoVereinsbank | |
| 19.05.05 | Swiss Life Underperformer | LB Rheinland-Pfalz | |
| 19.05.05 | Swiss Life Buy | M.M. Warburg | |
| 18.05.05 | Swiss Life Sell | Merck Finck & Co | |
| 17.05.05 | Adecco SA Neutral | UBS | |
| 18.05.05 | Roche Buy | Sarasin Research | |
| 17.05.05 | Kühne + Nagel International Market Perform | Vontobel | |
| 18.05.05 | Roche Overweight | JP Morgan | |
| 18.05.05 | Swisscom Underperform | Goldman Sachs | |
| 17.05.05 | UBS Outperform | Credit Suisse First Boston | |
| 17.05.05 | Lindt Neutral | Sarasin Research | |
| 17.05.05 | Clariant Sector Perform | Vontobel | |
| 13.05.05 | Roche Outperform | Goldman Sachs | |
| 17.05.05 | Swisscom Underweight | Lehman Brothers | |
| 17.05.05 | Swatch (I) Buy | Sarasin Research | |
| 17.05.05 | Swisscom Neutral | Credit Suisse First Boston | |
| 17.05.05 | Zurich Insurance Buy | Sarasin Research | |
| 17.05.05 | Swiss Life Underperformer | LB Rheinland-Pfalz | |
| 17.05.05 | Swisscom Neutral | Sarasin Research | |
| 17.05.05 | Swiss Life Neutral | HypoVereinsbank | |
| 11.05.05 | Holcim Halten | Helaba Trust | |
| 11.05.05 | Clariant Neutral | HypoVereinsbank | |
| 13.05.05 | Swiss Life Neutral | HypoVereinsbank | |
| 11.05.05 | Clariant Neutral | Sarasin Research | |
| 13.05.05 | Clariant Equal weight | Lehman Brothers | |
| 10.05.05 | Novartis Buy | Smith Barney Citigroup | |
| 10.05.05 | Clariant In-Line | Goldman Sachs | |
| 10.05.05 | UBS Buy | Merrill Lynch | |
| 10.05.05 | Clariant Neutral | Sarasin Research |
